These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases. Warnes DM; Tomas FM; Ballard FJ Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447 [TBL] [Abstract][Full Text] [Related]
5. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease. McKeran RO; Halliday D; Purkiss P; Royston P J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561 [TBL] [Abstract][Full Text] [Related]
6. Muscle diseases: the muscular dystrophies. McNally EM; Pytel P Annu Rev Pathol; 2007; 2():87-109. PubMed ID: 18039094 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of muscle wasting in myotonic dystrophy. Griggs RC; Jozefowicz R; Kingston W; Nair KS; Herr BE; Halliday D Ann Neurol; 1990 May; 27(5):505-12. PubMed ID: 2360792 [TBL] [Abstract][Full Text] [Related]
8. [Role of neurotrophic control in the pathogenesis of muscular dystrophy (a review)]. Bogdanov EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):452-9. PubMed ID: 3518319 [No Abstract] [Full Text] [Related]
9. Muscular dystrophy and other myopathies. Troponin activity of natural actomyosin from skeletal muscle. Furukawa T; Peter JB Arch Neurol; 1972 May; 26(5):385-90. PubMed ID: 5026268 [No Abstract] [Full Text] [Related]
10. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy. Stewart PM; Walser M; Drachman DB Muscle Nerve; 1982 Mar; 5(3):197-201. PubMed ID: 7088016 [TBL] [Abstract][Full Text] [Related]
11. Biochemical abnormalities of the sarcoplasmic reticulum in muscular dystrophy. Samaha FJ; Gergely J N Engl J Med; 1969 Jan; 280(4):184-8. PubMed ID: 4235816 [No Abstract] [Full Text] [Related]
12. Freeze fracture studies of muscle plasma membrane in human muscular dystrophy. Schotland DL; Bonilla E; Wakayama Y Acta Neuropathol; 1981; 54(3):189-97. PubMed ID: 7257728 [TBL] [Abstract][Full Text] [Related]
13. A new approach for carrier detection in Duchenne muscular dystrophy. Protein synthesis of muscle polyribosomes in vitro. Ionasescu V; Zellweger H; Conway TW Neurology; 1971 Jul; 21(7):703-9. PubMed ID: 4327312 [No Abstract] [Full Text] [Related]
15. Muscle wasting in the muscular dystrophies. Rennie MJ Dev Med Child Neurol; 1985 Aug; 27(4):524-7. PubMed ID: 4029524 [No Abstract] [Full Text] [Related]
16. Expression of myotonic dystrophy protein kinase in biopsied muscles. Tachi N; Kozuka N; Ohya K; Chiba S; Kikuchi K J Neurol Sci; 1995 Sep; 132(1):61-4. PubMed ID: 8523032 [TBL] [Abstract][Full Text] [Related]
17. Segmental myofiber necrosis in myotonic dystrophy - An immunoperoxidase study of immunoglobulins in skeletal muscle. Silver MM; Banerjee D; Hudson AJ Am J Pathol; 1983 Sep; 112(3):294-301. PubMed ID: 6351629 [TBL] [Abstract][Full Text] [Related]
18. Tissue culture studies of muscle disorders: Part 2. Biochemical studies, nerve-muscle culture, metabolic myopathies, and animal models. Witkowski JA Muscle Nerve; 1986 May; 9(4):283-98. PubMed ID: 3520307 [TBL] [Abstract][Full Text] [Related]
19. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine. Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577 [TBL] [Abstract][Full Text] [Related]